Tue, January 23, 2024

Glen Santangelo Upgraded (TEVA) to Strong Buy and Increased Target to $14 on, Jan 23rd, 2024

Glen Santangelo of Jefferies, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Strong Buy and Increased Target from $10 to $14 on, Jan 23rd, 2024.

Glen has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Glen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Amsellem of "Piper Sandler" Upgraded from Sell to Hold and Increased Target to $12 on, Wednesday, January 3rd, 2024


These are the ratings of the 2 analyists that currently disagree with Glen


  • Rajesh Kumar of "HSBC" Initiated at Strong Buy and Held Target at $13 on, Monday, December 18th, 2023
  • Ashwani Verma of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $13 on, Monday, November 27th, 2023